Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2023-07-20

Clinical Trial Update: Efficacy of Coenzyme Q10 Supplementation on Multi-Organ Dysfunction in Severely Burned Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Coenzyme Q10 supplementation for multi-organ dysfunction in severely burned patients was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Coenzyme Q10 (Coenzyme Q10)

Snippet

Sponsor: American Burn Association | Conditions: Multiple Organ Failure | Phase 3 | Status: WITHDRAWN